Funding agencies: This research was supported by the Tel Aviv Sourasky Medical Center Grant of Excellence and by grants from the Khan Foundation, the Israel Science Foundation Heritage Legacy, and the Michael J. Fox Foundation for Parkinson's Research. The funding sources had no involvement in the design, interpretation, or writing of this article.
Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation
Article first published online: 7 OCT 2013
© 2013 Movement Disorder Society
Volume 28, Issue 12, pages 1683–1690, October 2013
How to Cite
Mirelman, A., Heman, T., Yasinovsky, K., Thaler, A., Gurevich, T., Marder, K., Bressman, S., Bar-Shira, A., Orr-Urtreger, A., Giladi, N., Hausdorff, J. M. and on behalf of the LRRK2 Ashkenazi Jewish Consortium (2013), Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation. Mov. Disord., 28: 1683–1690. doi: 10.1002/mds.25587
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 25 OCT 2013
- Article first published online: 7 OCT 2013
- Manuscript Accepted: 4 JUN 2013
- Manuscript Revised: 18 MAY 2013
- Manuscript Received: 9 DEC 2012